Voyageur Pharmaceuticals Ltd.

VYYRF · OTC
Analyze with AI
8/31/2025
5/31/2025
2/28/2025
11/30/2024
Operating Activities
Net Income-$949-$544-$818-$459
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$299$395$80
Change in WC$134-$2-$966$456
Other Non-Cash$172-$14$9$3
Operating Cash Flow-$643-$261-$1,379$81
Investing Activities
PP&E Inv.-$84$0-$42-$35
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0-$21$0$0
Investing Cash Flow-$84-$21-$42-$35
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$1,178$0$914$167
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$40$21$981-$50
Financing Cash Flow$1,137$21$1,895$117
Forex Effect$0$0$0$0
Net Chg. in Cash$411-$261$473$163
Supplemental Information
Beg. Cash$275$639$166$3
End Cash$686$378$639$166
Free Cash Flow-$643-$261-$1,379$81
Voyageur Pharmaceuticals Ltd. (VYYRF) Financial Statements & Key Stats | AlphaPilot